Tucson, Ariz. – The University of Arizona has licensed two inventions developed in the Department of Chemistry and Biochemistry to startup MCR Therapeutics. The inventors – Drs. Minying Cai and Victor J. Hruby – developed targeted peptides through their research into drug design and bioactivity expression relating to hormone activity in the brain and periphery.Continue reading
Category Archives: AZBio News
For improving scientific reproducibility, biological samples are key
From humble roots in antiquity, the scientific method has come to dominate and transform modern society. Our insights into the natural world, from bacteria to black holes, are fruits of the scientific approach to understanding, as are the life-saving medical innovations society relies on.Continue reading
TGen-Barrow study shows drug penetration of glioblastoma
Innovative ‘Phase 0’ clinical trial successful in reaching deadly brain tumorsContinue reading
All of Us Research Program Begins National Enrollment Effort; Nine Banner Sites in Arizona Enrolling Volunteers
Events are planned across the nation to engage diverse communities in the national recruitment effort. In Arizona, Banner Health and the University of Arizona Health Sciences have been enrolling volunteers into the program as a National Institutes of Health pilot site since 2017.Continue reading
Salutaris Medical Devices, Inc. announces first subject treated in a clinical trial investigating the SMD-DA ophthalmic device for the treatment of neovascular Age-related Macular Degeneration (nAMD)
Salutaris Medical Devices, Inc. announced the first subject was treated in a multi-center clinical trial investigating the use of its ophthalmic brachytherapy device to treat neovascular Age-related Macular Degeneration (nAMD) on May 23, 2018.Continue reading
Pharmacology Researchers Seek Solutions to Opioid Epidemic
The UA’s focus has been on helping people with chronic pain without using narcotics or other addictive drugs.Continue reading
SenesTech Announces Patent Issued on Animal Fertility Control
SenesTech, Inc. (NASDAQ: SNES) announced the issuance of its patent on “REDUCING THE REPRODUCTIVE CAPACITY OF MAMMALS.” This intellectual property is a key aspect of ContraPest®, SenesTech’s flagship product that targets the reproductive capabilities of Norway and roof rats . The patent application was filed August 23, 2013, and has been issued on May 3, 2018 with patent number US 9,956,235.
Continue reading
UA Surgeons Developing New Tool to Detect Urine Blockage
Surgeons at the University of Arizona College of Medicine – Tucson are developing a tool that may make detecting urine blockage simpler for patients.Continue reading
UA Health Sciences and UA Researchers Awarded ABRC Grants Totaling Nearly $6M for Health Research
The three-year Arizona Biomedical Research Commission Awards will fund research relating to neuropathic and cancer pain, migraines, opioids, antibiotics, antivirals, sinusitis, obesity, diabetes, Parkinson’s disease, pulmonary disease and pediatric acute-onset neuropsychiatric syndrome.Continue reading